NOV 20, 2019 4:49 PM PST

Harnessing the Power of Natural Killer Cells to Fight Cancer

WRITTEN BY: Kara Marker

Manipulating the immune system’s population of natural killer cells could bolster therapies targeting cancer. A new study saw positive results investigating the cells in mice, and scientists show that human cells share the same promising physiological responses.

NK cells (brown) patrolling between cells of a healthy human lymph node. Source: Institute of Pathology, University of Bern

NK cells (brown) patrolling between cells of a healthy human lymph node. Source: Institute of Pathology, University of Bern

 

Natural killer (NK) cells are key components of the innate immune system, the arm of human immunity that responds first to pathogenic invasions with a non-specific attack. That attack could be via virus or cancer, but either way, NK cells seek to eliminate affected cells before the affliction has a chance to spread. They can do this one of two ways: release cell toxins for a direct kill, or activate cells affected by cancer or virus to self-destruct, a process called apoptosis.

During a viral invasion, NK cells manage T cells of the adaptive immune system, the second, more specific phase of immune response, by preventing them from unnecessarily killing host cells unaffected by the virus. NK cells do this by releasing “messenger molecules” to support immune defense.

But scientists from the recent study are presently more interested in NK cell-induced cellular self-destruction and its potential ability to improve anti-cancer clinical tactics. Researchers put “death ligands” under the microscope, scrutinizing these surface proteins’ abilities of interacting with “corresponding receptors” on the surface of target cells. One death ligand stood out during the study, a protein called “tumor necrosis factor-related apoptosis-inducing ligand,” or “TRAIL.”

Cancerous cells are more sensitive to TRAIL stimulation than healthy cells, making TRAIL-related therapies potential options for initiating the apoptotic self-destruction of cancer cells. One roadblock seems to stand in the way: in past studies, TRAIL has also been associated with negative health outcomes in particular infection cases. The present study offers a solution for navigating around this roadblock to effectively utilize TRAIL as an anti-cancer tactic.

Researchers began by studying the TRAIL response in a murine model of viral infection. Mice whose NK cells did not have TRAIL were better equipped to fight the virus than mice whose TRAIL was fully intact. NK cells perceived cellular signaling differently when they lacked TRAIL; they did less killing and more messenger molecule production, and T cells subsequently became more protective and were able to better remove virally infected cells. Researchers saw signs of similar activity in human NK cells too, indicating a potential for the reprogramming of NK cells to better target cancerous cells in addition to virally infected cells.

Sources: University of Bern, European Molecular Biology Organization (EMBO) Reports

About the Author
I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 07, 2022
Drug Discovery & Development
An Oral Insulin Pill is Getting Closer
SEP 07, 2022
An Oral Insulin Pill is Getting Closer
Diabetes is a chronic disease that requires constant monitoring. Patients have to check the level of sugar, or glucose i ...
OCT 21, 2022
Immunology
Researchers Find Cause of Flares in Rare Autoinflammatory Disease
OCT 21, 2022
Researchers Find Cause of Flares in Rare Autoinflammatory Disease
Mevalonate kinase deficiency (MKD) is a rare genetic disease caused by mutations in the mevalonate kinase gene, which en ...
OCT 18, 2022
Immunology
Cell Adhesion Molecules in Immune and Cancer Therapy
OCT 18, 2022
Cell Adhesion Molecules in Immune and Cancer Therapy
Introduction The immune system plays a dual role in inflammation and cancer development. Immune system effector cells ra ...
OCT 21, 2022
Drug Discovery & Development
Developing an intranasal vaccine for gonorrhea
OCT 21, 2022
Developing an intranasal vaccine for gonorrhea
Gonorrhea is a common sexually transmitted disease that is caused by the bacteria Neisseria gonorrhoeae (N. gonorrhoeae) ...
NOV 03, 2022
Drug Discovery & Development
A new vaccine against RSV can protect children from the virus immediately at birth
NOV 03, 2022
A new vaccine against RSV can protect children from the virus immediately at birth
As COVID-19 and flu virus infection rates are on the rise, another virus is now wreaking havoc on the United States ...
NOV 14, 2022
Cancer
Breast Cancer Vaccine Shows Promise as it Enters Phase 2 Trial
NOV 14, 2022
Breast Cancer Vaccine Shows Promise as it Enters Phase 2 Trial
About 20% of breast cancers exhibit elevated levels of a protein known as HER2.  You may have heard the classifier ...
Loading Comments...